nodes	percent_of_prediction	percent_of_DWPC	metapath
Fenoldopam—DRD5—attention deficit hyperactivity disorder	0.271	0.324	CbGaD
Fenoldopam—ADRA2C—attention deficit hyperactivity disorder	0.255	0.306	CbGaD
Fenoldopam—DRD1—attention deficit hyperactivity disorder	0.117	0.14	CbGaD
Fenoldopam—ADRA2A—attention deficit hyperactivity disorder	0.109	0.13	CbGaD
Fenoldopam—DRD2—attention deficit hyperactivity disorder	0.0826	0.099	CbGaD
Fenoldopam—DRD5—forebrain—attention deficit hyperactivity disorder	0.00167	0.0717	CbGeAlD
Fenoldopam—ADRA1D—forebrain—attention deficit hyperactivity disorder	0.00134	0.0575	CbGeAlD
Fenoldopam—DRD1—forebrain—attention deficit hyperactivity disorder	0.00128	0.0548	CbGeAlD
Fenoldopam—DRD5—nervous system—attention deficit hyperactivity disorder	0.000908	0.0389	CbGeAlD
Fenoldopam—DRD5—central nervous system—attention deficit hyperactivity disorder	0.000874	0.0375	CbGeAlD
Fenoldopam—DRD1—midbrain—attention deficit hyperactivity disorder	0.000844	0.0362	CbGeAlD
Fenoldopam—ADRA1A—forebrain—attention deficit hyperactivity disorder	0.000771	0.033	CbGeAlD
Fenoldopam—DRD2—forebrain—attention deficit hyperactivity disorder	0.000755	0.0324	CbGeAlD
Fenoldopam—ADRA1B—nervous system—attention deficit hyperactivity disorder	0.000745	0.0319	CbGeAlD
Fenoldopam—ADRA1D—nervous system—attention deficit hyperactivity disorder	0.000728	0.0312	CbGeAlD
Fenoldopam—ADRA1B—central nervous system—attention deficit hyperactivity disorder	0.000717	0.0307	CbGeAlD
Fenoldopam—ADRA1D—central nervous system—attention deficit hyperactivity disorder	0.000701	0.0301	CbGeAlD
Fenoldopam—DRD5—brain—attention deficit hyperactivity disorder	0.000694	0.0298	CbGeAlD
Fenoldopam—DRD1—nervous system—attention deficit hyperactivity disorder	0.000694	0.0298	CbGeAlD
Fenoldopam—DRD1—central nervous system—attention deficit hyperactivity disorder	0.000668	0.0286	CbGeAlD
Fenoldopam—ADRA1A—cardiovascular system—attention deficit hyperactivity disorder	0.000652	0.0279	CbGeAlD
Fenoldopam—ADRA2A—forebrain—attention deficit hyperactivity disorder	0.000586	0.0251	CbGeAlD
Fenoldopam—ADRA1B—brain—attention deficit hyperactivity disorder	0.000569	0.0244	CbGeAlD
Fenoldopam—ADRA1D—brain—attention deficit hyperactivity disorder	0.000557	0.0239	CbGeAlD
Fenoldopam—DRD1—brain—attention deficit hyperactivity disorder	0.00053	0.0227	CbGeAlD
Fenoldopam—DRD2—midbrain—attention deficit hyperactivity disorder	0.000499	0.0214	CbGeAlD
Fenoldopam—ADRA2C—midbrain—attention deficit hyperactivity disorder	0.000485	0.0208	CbGeAlD
Fenoldopam—ADRA1A—nervous system—attention deficit hyperactivity disorder	0.000418	0.0179	CbGeAlD
Fenoldopam—DRD2—nervous system—attention deficit hyperactivity disorder	0.00041	0.0176	CbGeAlD
Fenoldopam—ADRA1A—central nervous system—attention deficit hyperactivity disorder	0.000403	0.0173	CbGeAlD
Fenoldopam—ADRA2C—nervous system—attention deficit hyperactivity disorder	0.000399	0.0171	CbGeAlD
Fenoldopam—DRD2—central nervous system—attention deficit hyperactivity disorder	0.000395	0.0169	CbGeAlD
Fenoldopam—ADRA1A—cerebellum—attention deficit hyperactivity disorder	0.000394	0.0169	CbGeAlD
Fenoldopam—ADRA2A—midbrain—attention deficit hyperactivity disorder	0.000387	0.0166	CbGeAlD
Fenoldopam—DRD2—cerebellum—attention deficit hyperactivity disorder	0.000386	0.0165	CbGeAlD
Fenoldopam—ADRA2C—central nervous system—attention deficit hyperactivity disorder	0.000384	0.0165	CbGeAlD
Fenoldopam—ADRA2C—cerebellum—attention deficit hyperactivity disorder	0.000375	0.0161	CbGeAlD
Fenoldopam—ADRA1A—brain—attention deficit hyperactivity disorder	0.00032	0.0137	CbGeAlD
Fenoldopam—ADRA2A—nervous system—attention deficit hyperactivity disorder	0.000318	0.0136	CbGeAlD
Fenoldopam—DRD2—brain—attention deficit hyperactivity disorder	0.000313	0.0134	CbGeAlD
Fenoldopam—ADRA2A—central nervous system—attention deficit hyperactivity disorder	0.000306	0.0131	CbGeAlD
Fenoldopam—ADRA2C—brain—attention deficit hyperactivity disorder	0.000305	0.0131	CbGeAlD
Fenoldopam—ADRA2A—cerebellum—attention deficit hyperactivity disorder	0.000299	0.0128	CbGeAlD
Fenoldopam—ADRA2A—brain—attention deficit hyperactivity disorder	0.000243	0.0104	CbGeAlD
Fenoldopam—DRD5—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	2.66e-05	0.000187	CbGpPWpGaD
Fenoldopam—ADRA1D—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	2.64e-05	0.000185	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	2.62e-05	0.000184	CbGpPWpGaD
Fenoldopam—DRD1—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	2.61e-05	0.000183	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	2.6e-05	0.000183	CbGpPWpGaD
Fenoldopam—DRD1—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	2.59e-05	0.000182	CbGpPWpGaD
Fenoldopam—ADRA2B—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	2.58e-05	0.000182	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	2.58e-05	0.000181	CbGpPWpGaD
Fenoldopam—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	2.58e-05	0.000181	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	2.56e-05	0.00018	CbGpPWpGaD
Fenoldopam—ADRA2B—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	2.56e-05	0.00018	CbGpPWpGaD
Fenoldopam—ADRA1D—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	2.55e-05	0.000179	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	2.55e-05	0.000179	CbGpPWpGaD
Fenoldopam—DRD1—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	2.54e-05	0.000179	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	2.52e-05	0.000177	CbGpPWpGaD
Fenoldopam—DRD1—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	2.51e-05	0.000177	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	2.51e-05	0.000176	CbGpPWpGaD
Fenoldopam—ADRA1D—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	2.51e-05	0.000176	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	2.5e-05	0.000175	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	2.49e-05	0.000175	CbGpPWpGaD
Fenoldopam—DRD2—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	2.48e-05	0.000174	CbGpPWpGaD
Fenoldopam—ADRA1D—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	2.48e-05	0.000174	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	2.48e-05	0.000174	CbGpPWpGaD
Fenoldopam—DRD5—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	2.47e-05	0.000173	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	2.46e-05	0.000173	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	2.45e-05	0.000172	CbGpPWpGaD
Fenoldopam—ADRA2C—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	2.41e-05	0.00017	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	2.39e-05	0.000168	CbGpPWpGaD
Fenoldopam—ADRA1A—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	2.39e-05	0.000168	CbGpPWpGaD
Fenoldopam—ADRA2C—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	2.39e-05	0.000168	CbGpPWpGaD
Fenoldopam—ADRA2B—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	2.38e-05	0.000167	CbGpPWpGaD
Fenoldopam—ADRA1B—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	2.38e-05	0.000167	CbGpPWpGaD
Fenoldopam—ADRA1B—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	2.35e-05	0.000165	CbGpPWpGaD
Fenoldopam—DRD1—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	2.35e-05	0.000165	CbGpPWpGaD
Fenoldopam—DRD1—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	2.34e-05	0.000164	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	2.33e-05	0.000163	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	2.32e-05	0.000163	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	2.32e-05	0.000163	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	2.31e-05	0.000163	CbGpPWpGaD
Fenoldopam—DRD1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	2.31e-05	0.000162	CbGpPWpGaD
Fenoldopam—ADRA1D—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	2.31e-05	0.000162	CbGpPWpGaD
Fenoldopam—ADRA2B—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	2.31e-05	0.000162	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	2.28e-05	0.00016	CbGpPWpGaD
Fenoldopam—DRD1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	2.28e-05	0.00016	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	2.28e-05	0.00016	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	2.27e-05	0.000159	CbGpPWpGaD
Fenoldopam—ADRA2B—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	2.27e-05	0.000159	CbGpPWpGaD
Fenoldopam—DRD2—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	2.26e-05	0.000158	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	2.25e-05	0.000158	CbGpPWpGaD
Fenoldopam—DRD5—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	2.24e-05	0.000157	CbGpPWpGaD
Fenoldopam—ADRA2B—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	2.24e-05	0.000157	CbGpPWpGaD
Fenoldopam—ADRA2C—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	2.22e-05	0.000156	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	2.22e-05	0.000156	CbGpPWpGaD
Fenoldopam—ADRA2A—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	2.22e-05	0.000156	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	2.2e-05	0.000155	CbGpPWpGaD
Fenoldopam—DRD2—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	2.19e-05	0.000154	CbGpPWpGaD
Fenoldopam—ADRA1B—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	2.19e-05	0.000154	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	2.17e-05	0.000153	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	2.17e-05	0.000153	CbGpPWpGaD
Fenoldopam—DRD2—Circadian rythm related genes—EP300—attention deficit hyperactivity disorder	2.17e-05	0.000153	CbGpPWpGaD
Fenoldopam—DRD2—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	2.17e-05	0.000153	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	2.16e-05	0.000152	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	2.16e-05	0.000152	CbGpPWpGaD
Fenoldopam—ADRA2C—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	2.15e-05	0.000151	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	2.14e-05	0.00015	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	2.13e-05	0.00015	CbGpPWpGaD
Fenoldopam—DRD1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	2.13e-05	0.000149	CbGpPWpGaD
Fenoldopam—ADRA1B—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	2.12e-05	0.000149	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	2.12e-05	0.000149	CbGpPWpGaD
Fenoldopam—ADRA2C—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	2.12e-05	0.000149	CbGpPWpGaD
Fenoldopam—ADRA1A—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	2.11e-05	0.000148	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—ADRA2C—attention deficit hyperactivity disorder	2.1e-05	0.000148	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	2.1e-05	0.000147	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	2.09e-05	0.000147	CbGpPWpGaD
Fenoldopam—ADRA1A—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	2.09e-05	0.000147	CbGpPWpGaD
Fenoldopam—ADRA2C—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	2.09e-05	0.000147	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	2.09e-05	0.000147	CbGpPWpGaD
Fenoldopam—ADRA2B—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	2.09e-05	0.000147	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	2.08e-05	0.000146	CbGpPWpGaD
Fenoldopam—ADRA1B—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	2.08e-05	0.000146	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	2.08e-05	0.000146	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	2.06e-05	0.000145	CbGpPWpGaD
Fenoldopam—ADRA1B—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	2.06e-05	0.000145	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	2.05e-05	0.000144	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	2.04e-05	0.000144	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	2.04e-05	0.000144	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	2.03e-05	0.000143	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	2.03e-05	0.000143	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	2.02e-05	0.000142	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	2.02e-05	0.000142	CbGpPWpGaD
Fenoldopam—DRD2—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	2.02e-05	0.000142	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	1.99e-05	0.00014	CbGpPWpGaD
Fenoldopam—DRD2—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	1.97e-05	0.000138	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	1.96e-05	0.000138	CbGpPWpGaD
Fenoldopam—ADRA2A—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	1.96e-05	0.000138	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	1.96e-05	0.000137	CbGpPWpGaD
Fenoldopam—DRD2—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	1.95e-05	0.000137	CbGpPWpGaD
Fenoldopam—ADRA2C—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	1.95e-05	0.000137	CbGpPWpGaD
Fenoldopam—ADRA1A—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	1.94e-05	0.000137	CbGpPWpGaD
Fenoldopam—ADRA2A—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	1.94e-05	0.000137	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	1.93e-05	0.000135	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	1.92e-05	0.000135	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	1.92e-05	0.000135	CbGpPWpGaD
Fenoldopam—DRD2—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	1.92e-05	0.000135	CbGpPWpGaD
Fenoldopam—ADRA1B—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	1.92e-05	0.000135	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	1.9e-05	0.000133	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	1.9e-05	0.000133	CbGpPWpGaD
Fenoldopam—DRD2—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	1.9e-05	0.000133	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	1.89e-05	0.000133	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	1.89e-05	0.000133	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	1.89e-05	0.000133	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.89e-05	0.000133	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	1.88e-05	0.000132	CbGpPWpGaD
Fenoldopam—ADRA1A—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	1.88e-05	0.000132	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	1.87e-05	0.000131	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	1.85e-05	0.00013	CbGpPWpGaD
Fenoldopam—ADRA1A—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	1.85e-05	0.00013	CbGpPWpGaD
Fenoldopam—DRD2—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	1.83e-05	0.000129	CbGpPWpGaD
Fenoldopam—ADRA1A—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	1.83e-05	0.000128	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	1.82e-05	0.000128	CbGpPWpGaD
Fenoldopam—ADRA2A—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	1.81e-05	0.000127	CbGpPWpGaD
Fenoldopam—ADRA2C—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.78e-05	0.000125	CbGpPWpGaD
Fenoldopam—ADRA2C—Metabolism—TPH2—attention deficit hyperactivity disorder	1.78e-05	0.000125	CbGpPWpGaD
Fenoldopam—DRD2—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	1.77e-05	0.000125	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	1.77e-05	0.000124	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	1.77e-05	0.000124	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	1.76e-05	0.000124	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.76e-05	0.000124	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	1.76e-05	0.000123	CbGpPWpGaD
Fenoldopam—ADRA2C—Metabolism—DPYD—attention deficit hyperactivity disorder	1.76e-05	0.000123	CbGpPWpGaD
Fenoldopam—ADRA2A—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	1.75e-05	0.000123	CbGpPWpGaD
Fenoldopam—DRD2—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	1.74e-05	0.000123	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.74e-05	0.000122	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	1.74e-05	0.000122	CbGpPWpGaD
Fenoldopam—DRD2—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	1.72e-05	0.000121	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	1.72e-05	0.000121	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	1.71e-05	0.00012	CbGpPWpGaD
Fenoldopam—ADRA1A—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	1.7e-05	0.00012	CbGpPWpGaD
Fenoldopam—ADRA2A—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	1.7e-05	0.000119	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	1.69e-05	0.000119	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	1.68e-05	0.000118	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	1.66e-05	0.000117	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	1.64e-05	0.000115	CbGpPWpGaD
Fenoldopam—DRD1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	1.64e-05	0.000115	CbGpPWpGaD
Fenoldopam—ADRA2C—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.63e-05	0.000115	CbGpPWpGaD
Fenoldopam—ADRA1D—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	1.62e-05	0.000114	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	1.59e-05	0.000112	CbGpPWpGaD
Fenoldopam—ADRA2A—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	1.58e-05	0.000111	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.57e-05	0.00011	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	1.55e-05	0.000109	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	1.54e-05	0.000108	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.54e-05	0.000108	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.52e-05	0.000107	CbGpPWpGaD
Fenoldopam—DRD1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.49e-05	0.000105	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.47e-05	0.000103	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.47e-05	0.000103	CbGpPWpGaD
Fenoldopam—ADRA2B—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	1.46e-05	0.000103	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—TPH2—attention deficit hyperactivity disorder	1.45e-05	0.000102	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.45e-05	0.000102	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.45e-05	0.000102	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	1.44e-05	0.000101	CbGpPWpGaD
Fenoldopam—ADRA2C—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.43e-05	0.0001	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—DPYD—attention deficit hyperactivity disorder	1.43e-05	0.0001	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.41e-05	9.94e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.39e-05	9.76e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.37e-05	9.65e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.37e-05	9.63e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.36e-05	9.59e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	1.36e-05	9.59e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.36e-05	9.54e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.35e-05	9.47e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.35e-05	9.46e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	1.34e-05	9.43e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.33e-05	9.36e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.33e-05	9.35e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.33e-05	9.32e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.33e-05	9.32e-05	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	1.32e-05	9.3e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.28e-05	9.02e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.28e-05	9.02e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.28e-05	8.97e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.26e-05	8.87e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.26e-05	8.82e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.24e-05	8.71e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.24e-05	8.7e-05	CbGpPWpGaD
Fenoldopam—DRD2—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	1.24e-05	8.7e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.24e-05	8.69e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Hemostasis—EP300—attention deficit hyperactivity disorder	1.22e-05	8.6e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.22e-05	8.57e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.22e-05	8.54e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.2e-05	8.44e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.19e-05	8.38e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	1.19e-05	8.38e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.19e-05	8.38e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.17e-05	8.25e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.16e-05	8.18e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.16e-05	8.14e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.16e-05	8.12e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Hemostasis—EP300—attention deficit hyperactivity disorder	1.14e-05	8.04e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.14e-05	7.99e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.14e-05	7.98e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.12e-05	7.9e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.12e-05	7.88e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.12e-05	7.88e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.12e-05	7.86e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.12e-05	7.85e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	1.11e-05	7.79e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.1e-05	7.76e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.08e-05	7.61e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.08e-05	7.61e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Metabolism—COMT—attention deficit hyperactivity disorder	1.08e-05	7.6e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Metabolism—MAOA—attention deficit hyperactivity disorder	1.07e-05	7.54e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.05e-05	7.37e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.04e-05	7.34e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.04e-05	7.33e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.04e-05	7.32e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.03e-05	7.24e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.03e-05	7.23e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.02e-05	7.15e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.01e-05	7.1e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.01e-05	7.07e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	9.93e-06	6.98e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	9.81e-06	6.89e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	9.69e-06	6.81e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	9.39e-06	6.59e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Hemostasis—EP300—attention deficit hyperactivity disorder	9.29e-06	6.53e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	9.14e-06	6.42e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	9.11e-06	6.4e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	8.8e-06	6.18e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—COMT—attention deficit hyperactivity disorder	8.78e-06	6.17e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—MAOA—attention deficit hyperactivity disorder	8.72e-06	6.13e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	8.68e-06	6.1e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	8.49e-06	5.96e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	7.84e-06	5.5e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	7.32e-06	5.14e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	7.2e-06	5.06e-05	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—EP300—attention deficit hyperactivity disorder	7.01e-06	4.93e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	6.64e-06	4.67e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	6.4e-06	4.5e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	5.94e-06	4.18e-05	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	4.66e-06	3.27e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Metabolism—EP300—attention deficit hyperactivity disorder	4.64e-06	3.26e-05	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—EP300—attention deficit hyperactivity disorder	4.6e-06	3.23e-05	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—EP300—attention deficit hyperactivity disorder	4.15e-06	2.92e-05	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—EP300—attention deficit hyperactivity disorder	3.88e-06	2.72e-05	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—EP300—attention deficit hyperactivity disorder	3.82e-06	2.68e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—EP300—attention deficit hyperactivity disorder	3.77e-06	2.65e-05	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—EP300—attention deficit hyperactivity disorder	3.52e-06	2.47e-05	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	3.39e-06	2.38e-05	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	3.15e-06	2.21e-05	CbGpPWpGaD
